LYSOGENE ANNOUNCES COMPLETE ENROLLMENT IN ITS SAF-301 PHASE I/II CLINICAL TRIAL OF INTRACEREBRAL GENE THERAPY IN CHILDREN WITH SANFILIPPO TYPE A SYNDROME.

Posted by arletha on 03 07 2012 Leave a comment (0) Go to comments

Wydarzenia

Leave a Reply

Your email address will not be published. Required fields are marked *


CAPTCHA image